Andromeda Metals (ADN) H2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2026 earnings summary
11 Oct, 2026Executive summary
FY26 priorities were advancing the Great White Project (GWP) toward a final investment decision (FID) and progressing High Purity Alumina (HPA) commercialisation; no substantive mining production occurred.
GWP Early Works were completed, including site access, plant-pad earthworks, drilling and delivery of key long-lead equipment to Australia, leaving the project development-ready but dependent on funding and FID.
Continuous pilot production achieved HPA purity of 99.9986%, above the 4N threshold; a non-binding Traxys HOA targets a potential US sales-agency agreement.
Financial highlights
FY26 other income was $596,257, down 21.6% from $760,443 in FY25.
Net loss was $105.03m, including a one-off $98.94m exploration-asset impairment; excluding the impairment, net loss was $6.09m versus $6.04m in FY25.
Cash and cash equivalents were $3.20m at 30 June 2026, down from $7.14m; operating cash outflow was $5.17m and investing cash outflow was $11.55m.
Exploration and evaluation expenditure was $7.14m, up 154.7% from $2.80m in FY25, with spending predominantly directed to GWP advancement.
Outlook and guidance
FY27 priorities are to secure a value-accretive GWP funding pathway and advance HPA commercialisation; estimated equity funding to support Stage 1A+ FID was reduced to ~ $40m alongside Merricks Capital's credit-approved $75m facility.
The HPA program is intended to optimise the continuous flowsheet, produce customer samples and assess amorphous silica and gallium as potential co-products; a pre-feasibility study is being advanced.
GWP Stage 1A+ targets nominal production of 100,000 wet metric tonnes per year, supported by four binding offtake agreements; development remains subject to funding and FID.
Latest events from Andromeda Metals
- Advanced GWP and HPA projects, but urgent funding needs remain as cash falls below one quarter.ADN
Q4 2026 TU - Progress on Great White and HPA projects continued, but funding delays impacted cash flow.ADN
Q3 2026 TU - Construction-ready kaolin project advances with secured offtakes and narrowed net loss.ADN
H2 2024 - Significant impairment and funding needs led to a $101.6 million net loss despite capital raised.ADN
H1 2026 - AGM confirmed strong project economics, secured offtakes, and advancing funding and development.ADN
AGM 2025 - Advancing two high-value mineral projects with secured funding, offtakes, and strong market outlook.ADN
Noosa Mining Investor Conference - Secured major funding, advanced HPA project, and raised $13M to support ongoing development.ADN
Q1 2026 TU - Advancing a de-risked kaolin project and innovative HPA venture with robust market outlook.ADN
Investor Presentation - Shovel-ready kaolin project advances with strong economics, secured offtakes, and active funding efforts.ADN
Investor Update